Phospholipase D1 Acts through Akt/TopBP1 and RB1 to Regulate the E2F1-Dependent Apoptotic Program in Cancer Cells
Dong Woo Kang1,2, Shin Wha Lee1,3, Won Chan Hwang2
1Institute of Innovative Cancer Research, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Abstract:
The RB1/E2F1 signaling pathway is frequently deregulated in colorectal cancer and has been suggested to intersect with Wnt/β-catenin and PI3K/Akt pathways, but molecular evidence for this link is lacking. In this study, we demonstrate that phospholipase D1 (PLD1), a transcriptional target of β-catenin/TCF4, orchestrates functional interactions between these pathways during intestinal tumor development. Overexpression of PLD1 in intestinal epithelial cells protected cells from apoptosis induced by PLD1 ablation in the Apcmin/+ mouse model of intestinal tumorigenesis. Mechanistic investigations revealed that genetic and pharmacologic targeting of PLD1 promote the E2F1-dependent apoptotic program via both miR-192/4465-mediated downregulation of RB1 and inhibition of Akt-TopBP1 pathways. Moreover, the miRNA-RB1 axis and Akt pathway also contributed to the PLD1-mediated self-renewal capacity of colon cancer-initiating cells. Finally, PLD1-driven E2F1 target gene expression positively correlated with tumor stage in patients with colorectal cancer. Overall, our findings suggest that PLD1 mediates cross-talk between multiple major signaling pathways to promote the survival and malignancy of colon cancer cells and may therefore represent an ideal signaling node for therapeutic targeting. Cancer Res; 77(1); 142-52. ©2016 AACR.
Insights
Phospholipase D1 (PLD1) links key cancer pathways in colorectal cancer. Targeting PLD1 promotes apoptosis and may offer a new therapeutic strategy for colon cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Signaling
Background:
- The RB1/E2F1 pathway is frequently altered in colorectal cancer (CRC).
- Potential links between RB1/E2F1, Wnt/β-catenin, and PI3K/Akt pathways in CRC are suggested but lack molecular evidence.
Purpose of the Study:
- To investigate the role of phospholipase D1 (PLD1) in mediating interactions between major signaling pathways in colorectal cancer development.
- To explore PLD1 as a potential therapeutic target in colon cancer.
Main Methods:
- Utilized the Apcmin/+ mouse model for intestinal tumorigenesis studies.
- Investigated PLD1's role in apoptosis, cell survival, and cancer-initiating cell self-renewal.
- Analyzed the miR-192/4465-RB1 axis and Akt-TopBP1 pathways.
- Correlated PLD1-driven E2F1 target gene expression with tumor stage in CRC patients.
Main Results:
- PLD1, a β-catenin/TCF4 target, orchestrates functional interactions between Wnt/β-catenin, PI3K/Akt, and RB1/E2F1 pathways.
- PLD1 overexpression protected intestinal cells from apoptosis in the Apcmin/+ model.
- Targeting PLD1 induced E2F1-dependent apoptosis via miR-192/4465-mediated RB1 downregulation and Akt-TopBP1 inhibition.
- PLD1 also contributed to colon cancer-initiating cell self-renewal through the miRNA-RB1 axis and Akt pathway.
- PLD1-driven E2F1 target gene expression correlated with advanced colorectal cancer stage.
Conclusions:
- PLD1 acts as a crucial signaling node, mediating cross-talk between major pathways to enhance colon cancer cell survival and malignancy.
- PLD1 represents a promising therapeutic target for colorectal cancer treatment.
More Related Videos
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
Amplifying Signals via Enzymatic Cascade
Negative Regulator Molecules


